Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Johnson & Johnson (JNJ)

149.17   0.97 (0.65%) 01-17 16:00
Open: 148.41 Pre. Close: 148.2
High: 149.41 Low: 147.93
Volume: 8,964,307 Market Cap: 392596M
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of products in the health care field within its Consumer, Pharmaceutical and Medical Devices segments.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 149.5 - 149.942 149.942 - 150.436
Low: 146.565 - 147.113 147.113 - 147.727
Close: 148.205 - 149.031 149.031 - 149.956

Technical analysis

as of: 2020-01-17 4:37:32 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 174.51     One year: 203.83
Support: Support1: 143.79    Support2: 140.31
Resistance: Resistance1: 149.41    Resistance2: 174.51
Pivot: 145.88
Moving Average: MA(5): 147.32     MA(20): 145.89
MA(100): 135.43     MA(250): 135.82
MACD: MACD(12,26): 1.89     Signal(9): 1.87
Stochastic oscillator: %K(14,3): 93.98     %D(3): 90.93
RSI: RSI(14): 77.50
52-week: High: 149.41  Low: 125.00  Change(%): 15.8
Average Vol(K): 3-Month: 640972  10-Days: 620899

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
JNJ has closed above the upper band by 11.7%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 23% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Johnson & Johnson : J&J Case Damages Slashed By Judge | MarketScreener
By Peter Loftus A Philadelphia judge has reduced the amount of punitive damages Johnson & Johnson must pay in a lawsuit over its antipsychotic Risperdal to $6.8 million from the $8… | January 18, 2020

US Court Slashes USD 8 Billion Johnson & Johnson Damages over Drug Side Effect to USD 6.8 Million
The court said the company now only is liable for punitive damages of USD 6.8 million, although the company still intends to appeal the decision.

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Drug Manufacturers - Major
Shares Out. (M) 2630.00
Shares Float (M) 2630.00
% Held by Insiders 0.07
% Held by Institutions 69.71
Shares Short (K) 16450
Shares Short P. Month (K)

Stock Financials

EPS 5.240
Book Value (p.s.) 22.120
PEG Ratio 2.84
Profit Margin 17.32
Operating Margin 26.11
Return on Assets (ttm) 8.6
Return on Equity (ttm) 23.0
Qtrly Rev. Growth 1.9
Gross Profit (p.s.) 20.757
Sales Per Share
EBITDA (p.s.) 10.745
Qtrly Earnings Growth -55.40
Operating Cash Flow (M) 23260.00
Levered Free Cash Flow (M) 25750.00

Stock Valuations

P/E 28.47
P/E Growth Ratio 0.01
P/BV 6.74
P/S 4.85
P/CF 16.87

Dividends & Splits

Dividend 3.700
Dividend Yield 0.02
Dividend Pay Date 2020-03-10
Ex-Dividend Date 2020-02-24
Forward Dividend 3.800
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.